Medpace Price to Book Value vs PPandE Turnover Analysis
MEDP Stock | USD 382.44 2.61 0.68% |
Trend analysis of Medpace Holdings balance sheet accounts such as Other Current Liab of 70.6 M provides information on Medpace Holdings' total assets, liabilities, and equity, which is the actual value of Medpace Holdings to its prevalent stockholders. By breaking down trends over time using Medpace Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Medpace |
About Medpace Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Medpace Holdings at a specified time, usually calculated after every quarter, six months, or one year. Medpace Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medpace Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medpace currently owns. An asset can also be divided into two categories, current and non-current.
Medpace Holdings Balance Sheet Chart
Medpace Holdings Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Medpace Holdings uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Medpace Holdings' Common Stock Total Equity is relatively stable compared to the past year. As of 04/18/2024, Non Current Liabilities Total is likely to grow to about 182.2 M, while Other Liabilities is likely to drop slightly above 20 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Medpace Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medpace Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Medpace Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.As of 04/18/2024, Sales General And Administrative To Revenue is likely to grow to 0.12, while Selling General Administrative is likely to drop slightly above 95.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 328.2M | 432.4M | 524.5M | 278.6M | Total Revenue | 1.1B | 1.5B | 1.9B | 2.0B |
Medpace Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Medpace Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medpace Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 37.6M | 37.7M | 37.7M | 33.7M | 31.8M | 29.1M | |
Total Assets | 1.1B | 1.4B | 1.7B | 1.4B | 1.7B | 1.3B | |
Short Long Term Debt Total | 45.2M | 115.1M | 131.0M | 188.9M | 142.1M | 156.5M | |
Other Current Liab | 19.0M | 23.5M | 27.6M | 257.7M | 40.4M | 70.6M | |
Total Current Liabilities | 343.0M | 440.1M | 557.2M | 803.5M | 925.1M | 971.4M | |
Total Stockholder Equity | 726.3M | 805.8M | 952.9M | 386.4M | 559.0M | 654.5M | |
Other Liab | 28.6M | 29.6M | 18.8M | 23.8M | 21.4M | 20.0M | |
Net Tangible Assets | 9.5M | 96.9M | 249.2M | (314.0M) | (361.1M) | (379.2M) | |
Property Plant And Equipment Net | 99.4M | 198.8M | 222.7M | 248.9M | 265.4M | 138.1M | |
Current Deferred Revenue | 192.4M | 255.7M | 344.6M | 462.7M | 559.9M | 587.9M | |
Net Debt | (86.7M) | (162.6M) | (330.3M) | 160.6M | (103.3M) | (98.2M) | |
Retained Earnings | 68.1M | 115.2M | 235.0M | (359.8M) | (221.6M) | (210.6M) | |
Accounts Payable | 22.4M | 26.6M | 25.7M | 33.1M | 31.9M | 21.9M | |
Cash | 131.9M | 277.8M | 461.3M | 28.3M | 245.4M | 143.1M | |
Non Current Assets Total | 826.0M | 917.0M | 969.0M | 1.0B | 1.1B | 1.0B | |
Non Currrent Assets Other | 9.5M | 8.8M | 17.4M | 21.1M | 25.0M | 26.2M | |
Other Assets | 9.9M | 123.1M | 42.6M | 69.2M | 79.6M | 83.6M | |
Cash And Short Term Investments | 131.9M | 277.8M | 461.3M | 28.3M | 245.4M | 143.1M | |
Net Receivables | 155.7M | 161.0M | 186.4M | 253.4M | 298.4M | 163.0M | |
Common Stock Total Equity | 355K | 356K | 360K | 309K | 278.1K | 279.2K | |
Liabilities And Stockholders Equity | 1.1B | 1.4B | 1.7B | 1.4B | 1.7B | 1.3B | |
Non Current Liabilities Total | 73.8M | 144.8M | 149.8M | 162.6M | 172.7M | 182.2M | |
Other Current Assets | 29.4M | 34.9M | 43.2M | 52.3M | 50.0M | 32.1M | |
Other Stockholder Equity | 660.6M | 690.3M | 722.4M | 758.3M | 790.4M | 699.5M | |
Total Liab | 416.8M | 584.9M | 707.0M | 966.1M | 1.1B | 685.5M | |
Deferred Long Term Liab | 12.8M | 13.6M | 1.1M | 1.1M | 1.2M | 1.2M | |
Property Plant And Equipment Gross | 99.4M | 198.8M | 222.7M | 248.9M | 344.8M | 362.0M | |
Total Current Assets | 317.0M | 473.7M | 690.9M | 334.0M | 593.8M | 338.7M | |
Accumulated Other Comprehensive Income | (2.7M) | (131K) | (4.8M) | (12.4M) | (10.1M) | (9.6M) | |
Short Term Debt | 109.3M | 134.4M | 159.3M | 50M | 293.0M | 307.6M | |
Intangible Assets | 54.4M | 46.5M | 41.4M | 38.0M | 35.8M | 34.0M | |
Common Stock | 355K | 356K | 360K | 309K | 308K | 275.9K | |
Property Plant Equipment | 99.4M | 85.0M | 93.2M | 109.8M | 126.3M | 74.3M | |
Capital Surpluse | 666.6M | 695.9M | 727.9M | 770.8M | 886.4M | 714.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.165 | Earnings Share 8.89 | Revenue Per Share 61.384 | Quarterly Revenue Growth 0.265 | Return On Assets 0.1399 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.